title: Nosocomial bloodstream infections with Burkholderia stabilis.
abstract: Burkholderia stabilis was grown from blood cultures of seven patients presenting with signs and symptoms of septicaemia in the intensive care unit at Mersin University Hospital, Mersin, Turkey between July and October 2002. Four patients had one B. stabilis-positive blood culture, two patients had two, and one patient had four. Isolates from six of seven patients had the same resistotype and random amplified polymorphic DNA analysis type. Despite treatment with ciprofloxacin and imipenem, to which the strains were susceptible, all patients died one to eight days after isolation of B. stabilis from their blood. B. stabilis should be regarded as an opportunistic pathogen that may cause nosocomial bloodstream infections.
authors.affiliation: Faculty of Medicine, Mersin University, Mersin, Tip Fakultesi, Mikrobiyoloji ve Klinik Mikrobiyoloji AD, 33079 Mersin, Turkey. fezaotag@mersin.edu.tr
authors.forename: F
authors.initials: F
authors.lastname: Otağ
authors.forename: G
authors.initials: G
authors.lastname: Ersöz
authors.forename: M
authors.initials: M
authors.lastname: Salcioğlu
authors.forename: C
authors.initials: C
authors.lastname: Bal
authors.forename: I
authors.initials: I
authors.lastname: Schneider
authors.forename: A
authors.initials: A
authors.lastname: Bauernfeind
mesh_terms: D000293:Adolescent; D000328:Adult; D000368:Aged; D016470:Bacteremia / Q000453:epidemiology / Q000382:microbiology* / Q000517:prevention & control; D015373:Bacterial Typing Techniques; D019117:Burkholderia / Q000145:classification / Q000235:genetics; D019121:Burkholderia Infections / Q000453:epidemiology / Q000382:microbiology* / Q000517:prevention & control; D002939:Ciprofloxacin / Q000627:therapeutic use; D003428:Cross Infection / Q000453:epidemiology / Q000382:microbiology* / Q000517:prevention & control; D024881:Drug Resistance, Bacterial; D004359:Drug Therapy, Combination / Q000627:therapeutic use; D017052:Hospital Mortality; D006785:Hospitals, University; D006801:Humans; D015378:Imipenem / Q000627:therapeutic use; D017053:Infection Control; D007362:Intensive Care Units; D008297:Male; D008875:Middle Aged; D009894:Opportunistic Infections / Q000453:epidemiology / Q000382:microbiology* / Q000517:prevention & control; D019105:Random Amplified Polymorphic DNA Technique; D012189:Retrospective Studies; D012307:Risk Factors; D016896:Treatment Outcome; D014421:Turkey / Q000453:epidemiology
chemical_list: D002939:Ciprofloxacin; D015378:Imipenem